Key dopamine receptor antagonists companies such as Chimerix ... and vomiting side effects caused by a glucagon-like peptide 1 (GLP-1) agonist medication. In September 2024, Engrail Therapeutics ...

Researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion of the brain that controls approach vs. avoidance behavior. Mount Sinai researchers ...

Morningstar brands and products Company Portfolio ...

Now, new research suggests the drug’s effectiveness is less about the amount of dopamine it produces and more about the number and type of receptors that respond to it. Conditions where a person ...

"Renal-dose" dopamine is widely used in clinical practice despite the controversial benefit in the prophylaxis and treatment of acute renal failure. Goldberg et al. [1] were the first to ...

a novel dopamine-1 receptor antagonist, in subjects with Tourette syndrome. The company will meet with the Food and Drug Administration and other global health authorities to discuss the ...